Dysplasia of epithelial- and mesenchymal-derived organs which include tooth, sweat gland, hair and nail is called ectodermal dysplasias (EDs) (Itin & Fistarol, 2004). It can be inherited as autosomal dominant, autosomal recessive and X-linked recessive modes (X-linked recessive type, X-linked hypohidrotic ectodermal dysplasias, XLHED) (Priolo & Lagana, 2001). The prevalence of XLHED is about less than one in per 100, 000 (Chassaing et al., 2006).
Previous studies have confirmed that XLHED is caused by the nucleotide variation of Ectodysplasin A (EDA) gene. The EDA gene has at least nine transcripts because it has extensive alternative splicing (Kere et al., 1996). The longest isoform is EDA-A1 which encodes 391-amino acid (Döffinger et al., 2001; Headon et al., 2001). The variations in EDA gene are also detected in isolated hypodontia patients (Yin & Bian, 2015; Yin & Bian, 2016). There are more than 100 EDA gene mutations which have been detected in XLHED patients (Tao et al., 2006).
EDs can also present as part of a syndrome, which includes ectodermal dysplasia, hypohidrotic, with immune deficiency, ectodermal dysplasia and neurosensory deafness and ectodermal dysplasia with adrenal cyst. The causative gene for syndromic EDs includes NEMO and TP63 gene (Yin et al., 2010).
In the current study, we reported a large Chinese XLHED pedigree. Nucleotide sequence analysis confirmed a new XLHED-related EDA frameshift mutation. Pyrosequencing analysis was used to study the EDA gene promoter’s methylation state of pedigree’s carriers. Furthermore, we performed the prenatal diagnosis for one pregnancy carrier.
Materials & Methods
The protocol of this study was approved by the Institutional Review Board (IRB) of Hospital and School of Stomatology, Wuhan University (200702). All contents in this study were carried out following the approved guidelines. All participants or their guardians signed the written informed consents. This study followed the recommendation of STROBE guidelines (https://www.strobe-statement.org/index.php?id=strobe-home).
Pedigree diagnosis and DNA sample collection
The proband was the patient of School and Hospital of Stomatology, Wuhan University. Physical examination was performed as thoroughly as possible by two dentists respectively. The panoramic radiograph film was used to evaluate the development of tooth and alveolar bone. Then other family members were interviewed and examined. The peripheral blood samples (10 ml) were collected using EDTA 2Na as anticoagulant. DNA was extracted from leukocytes using standard proteinase-K phenol chloroform methods (Yin et al., 2010).
Polymerase chain reaction, mutation screening and protein structural analysis
The entire coding region and exon-intron boundaries of EDA gene were amplified and purified by the same way with our previous study (Yin, Ye & Bian, 2012). In brief, the coding exons and intron-exon boundaries of EDA gene were amplified with specific primers. The polymerase chain-reaction (PCR) purification kit (Omega, Norcross, GA, USA) was used to purify the amplified fragments.
The nucleotide sequence was detected with an ABI PRISM 3730 genetic analyzer and analyzed in BLAST database of the National Center for Biotechnology Information (NCBI). After identifying the nucleotide variant in EDA gene, two hundred unrelated healthy controls were recruited to exclude the possibility of Single nucleotide polymorphism (SNP). The protein structure of wild-type and mutant EDA protein were constructed by Swiss-pdbViewer 4.0 software.
Chorion cells were obtained with the help of ultrasonic at gestational age of 13 weeks. The QIAamp® DNA Mini Kit (QIAGEN, Hilden, Germany) was used for DNA isolation from chorion cells. The determination of fetal’s gender was based on the detection of SRY gene. Primers for SRY genes are F: 5′-CATGAACGCATTCATCGTGTGGTC-3′ and R: 5′-CTGCGGGAAGCAACTGCAATTCTT-3′ (Shahid et al., 2004). The mutation detection was the same with “Polymerase chain reaction, mutation screening and protein structural analysis”.
Methylation analysis of EDA gene promoter
The methylation state of EDA gene promoter was determined in the same way with our previous work (Yin et al., 2013). In brief, the CpGenome DNA Modification Kit (Intergen Company, Purchase, NY, USA) was used to perform the bisulfite modification of the genome. The sequence (“CGgctgaggcagaCGcagCGgctccCG”) in EDA gene promoter was used to determine the methylation state. After amplification, the product was sequenced with PYRO MARK ID (BIOTAGE).
Chi-Square Test and ANOVA were used to analyze the differences in methylation state of EDA gene promoter. It was considered statistically significant when the P value < 0.05.
In this study, we interviewed seven family members (II:1, II:3, II:4, III:4, III:5, III:6 and IV:1), in which two males were patients and three female were carriers. The two male patients share similar phenotype which includes the characteristic face of XLHED, hypohidrotic, and tooth agenesis. Three carriers only had abnormal shape of teeth and sparse hair (Fig. 1).
Analysis of EDA gene mutation and protein structural changes
After making the diagnosis, we aimed to determine the causative gene of this pedigree. We screened the coding sequence of the EDA gene. A new frameshift mutation, 171–172insGG, in exon one was identified in all patients and carriers (Fig. 2). All healthy members in this family do not have the frameshift mutation. The healthy controls did not have this variation in EDA gene. This frameshift mutation was predicted to result in an immediate premature stop codon in exon one. Mutant EDA only had 62 amino acids. According to the analysis of Swiss-pdbViewer software, the mutant residue located on the outer surface of the EDA protein. The structure of mutant EDA was more compact compared with that of wildtype EDA. The direction of H-band and electrostatic potential also greatly changed (Fig. 3).
Methylation state of EDA gene promoter
In order to analyze the role of inactivation of X chromosome in changes of carrier’s phenotype, we performed methylation state analysis of EDA gene promoter for one carrier (III:4). The methylation frequency of four sites in EDA gene promoter was showed in Table 1. Compared to the 95% CI for methylation of each site (Yin et al., 2013), two out of these four sites of carrier III:4 exhibited hypermethylation state. While on site was in hypomethylation level.
One of pedigree’s carriers (III:4) was pregnant after we determined the causative gene mutation of this family. With the informed consent, we performed prenatal diagnosis for her. Chorion cells were isolated under ultrasonic at gestational age of 13 weeks. The genomic DNA was immediately extracted. The short tandem repeat (STR) analysis was used to exclude the mixture of mother tissue in chorion cells. We determined that the fetus was female. The result was reliable which was confirmed by the positive and negative control. The nucleotide sequencing analysis indicated that the fetus was a carrier. We checked the health condition of this child every year. She had mild hypodontia of deciduous teeth at age six.
It is well known that XLHED patients have well-characterized phenotype. Patients suffer from the deformity of tooth, hair, skin, alveolar bone and suboriferous. The patients in this pedigree with frameshift mutation of EDA gene had similar characters with our previous XLHED patients who had missense mutation and nonsense mutation in different exons. Therefore we had the same conclusion with the previous report that there was no evident correlation between genotype and phenotype in XLHED patients (Yin, Ye & Bian, 2012).
EDA is a trimeric type II membrane protein and has intracellular domain, transmembrane domain, furin subdomain, collagen subdomain and tumor necrosis factor (TNF) homology subdomain (Schneider et al., 2001). The TNF homology domain plays a critical role in the homotrimerization of ligands and the binding to the receptor (Döffinger et al., 2001). The frameshift mutation, 171-172insGG, stopped EDA transcript at the 62nd amino acid. Interceptive EDA only had intracellular domain and transmembrane domain. Therefore, its ligand, EDAR, neither bind to it nor get the intracellular signals. Furthermore, mutant EDA was unable to form the trimer.
In XLHED pedigree, heterozygous carriers show only minor to moderate degrees of typical features (Cambiaghi et al., 2001). Aberrant methylation of EDA gene was thought to be a reasonable explanation because severe manifestations of female in X-linked recessive disorder might be related to skewing of X-inactivation (Lyon, 2002). Our previous study suggested that Chinese XLHED carriers were inclined to have a hypermethylated EDA promoter (Yin et al., 2013). Carriers with hypermethylated EDA promoter had a higher chance to suffer conical shaped tooth and nail dysplasia than carriers with hypomethylated EDA promoter. In the present study, female carriers also exhibited abnormal shaped teeth. Therefore, we also analyzed the EDA gene promoter’s methylation state of one female carrier (III:4). Our results suggested that two detected sites in EDA gene promoter were hypermethylated compared to that of healthy control. However, one of these four detected sites was in the hypomethylated level. Therefore, we speculated that there was other mechanisms involving in the regulation of XLHED carrier’s phenotype.
During the past several years, prenatal determination was practicable through DNA testing on embryo (Rigolet et al., 2007). While only few publications reported the prenatal diagnosis in XLHED pedigree. More studies were needed to summarize its merits. Our experience indicated that prenatal diagnosis which relied on chorion cells performed very well. The diagnosis can be applied very early, in the first trimester, during pregnancy. Therefore, it is a prerequisite for the optimal care of the carrier’s pregnant and her fetus.
A novel EDA frameshift mutation was confirmed in a large Chinese XLHED pedigree. Mutant EDA only had 62 amino acids, which caused great changes compared with the wild-type EDA.